Kirkland Advises Galderma and the EQT-Led Consortium on Structuring, Implementation of Galderma's IPO on the SIX Swiss Exchange
March 27, 2024
March 27, 2024
CHICAGO, Illinois, March 27 -- Kirkland and Ellis, a law firm, issued the following news release:
Kirkland & Ellis advised Galderma Group AG, a leading maker of dermatological products, on the structuring and implementation of its IPO on the SIX Swiss Exchange. Kirkland advised EQT on the original acquisition of Galderma (formerly Nestle Skin Health) in 2019 by a consortium of investors led by EQT alongside the Abu Dhabi Investment Authority, GIC and other institutional investor . . .
Kirkland & Ellis advised Galderma Group AG, a leading maker of dermatological products, on the structuring and implementation of its IPO on the SIX Swiss Exchange. Kirkland advised EQT on the original acquisition of Galderma (formerly Nestle Skin Health) in 2019 by a consortium of investors led by EQT alongside the Abu Dhabi Investment Authority, GIC and other institutional investor . . .